| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alzheimer's Association Update September 2010
|
|
|
2010
|
6 |
5 |
p. 429-430
2 p.
|
article
|
| 2 |
Alzheimer's disease, a multifactorial disorder seeking multitherapies
|
Iqbal, Khalid
|
|
2010
|
6 |
5 |
p. 420-424
5 p.
|
article
|
| 3 |
Cerebral atrophy, apolipoprotein E ε4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment
|
Okonkwo, Ozioma C.
|
|
2010
|
6 |
5 |
p. 404-411
8 p.
|
article
|
| 4 |
Contents
|
|
|
2010
|
6 |
5 |
p. A2-
1 p.
|
article
|
| 5 |
Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells
|
Calciano, Margaret A.
|
|
2010
|
6 |
5 |
p. 386-393
8 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2010
|
6 |
5 |
p. A4-
1 p.
|
article
|
| 7 |
Influence of apolipoprotein E ε4 on rates of cognitive and functional decline in mild cognitive impairment
|
Whitehair, Danielle C.
|
|
2010
|
6 |
5 |
p. 412-419
8 p.
|
article
|
| 8 |
Medical and Scientific Advisory Council
|
|
|
2010
|
6 |
5 |
p. A5-
1 p.
|
article
|
| 9 |
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss
|
Mielke, Michelle M.
|
|
2010
|
6 |
5 |
p. 378-385
8 p.
|
article
|
| 10 |
Requiring an amyloid-β1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
|
Schneider, Lon S.
|
|
2010
|
6 |
5 |
p. 367-377
11 p.
|
article
|
| 11 |
Subscriber Information
|
|
|
2010
|
6 |
5 |
p. A1-
1 p.
|
article
|
| 12 |
Web-based application to project the burden of Alzheimer's disease
|
Colantuoni, Elizabeth
|
|
2010
|
6 |
5 |
p. 425-428
4 p.
|
article
|
| 13 |
White matter is altered with parental family history of Alzheimer's disease
|
Bendlin, Barbara B.
|
|
2010
|
6 |
5 |
p. 394-403
10 p.
|
article
|
Journal description